Industry News

Genzyme Corp. intends to build a recombinant protein manufacturing plant in Framingham, Ma. The 300,000-sf facility is estimated to be running by 2004. In Waterford, Ireland, Genzyme has purchased a 120,000-sf plant for manufacturing Renagel, with a multiproduct manufacturing facility planned nearby.

Tularik Texas, a subsidiary of South San Francisco-based biotech firm Tularik, is leasing and building out a laboratory space in Dallas. The 2,300-sf facility will focus on anti-fungal and anti-bacterial drug development and is due to open in September.

Emmanuel College in Boston has partnered with Merck & Co. Inc. on a planned 300,000-sf research center. The Merck-owned facility on Emmanuel's 16-acre campus will foster a relationship between the college's biology students and Merck.   

Emerson College is planning several new developments, including a new residence hall and college center housing additional athletic and student activity space. Adjacent to the Majestic Theatre, Emerson has planned a $30 million, 11-story performance and production center containing offices, classrooms, laboratories, a television studio, an exhibition area, two small theaters, and dressing rooms for the Majestic, which will also be renovated.  

Boston College is undertaking several campus projects, including a $90 million renovation of the Higgins Science Building estimated to reach completion in fall of 2002. Construction has begun on a $36 million, 156,000-sf office facility on the lower campus, with plans for a $120 million development of three interconnected buildings (housing classrooms, offices, student services, and an auditorium) to follow.